Who owns Spectrum Pharmaceuticals?

Key details on Spectrum Pharmaceuticals (Ticker: SPPI)

Who owns Spectrum Pharmaceuticals?

Is SPPI a good stock to own? Find out who bought Spectrum Pharmaceuticals, who sold Spectrum Pharmaceuticals (SPPI) stock, and who holds a large position in Spectrum Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
BlackRock Fund Advisors 5.99M $40.96M June 30, 2015
STATE STREET CORPORATION 5.01M $34.30M June 30, 2015
ARMISTICE CAPITAL 4.44M $30.34M June 30, 2015
Vanguard 4.32M $29.61M June 30, 2015
FMR 4.24M $29.02M June 30, 2015
Baker Bros. Advisors 3.32M $38.85M Sept. 30, 2012
Wellington Management Company 2.43M $16.65M June 30, 2015
Millennium Management 2.28M $13.84M March 31, 2015
BlackRock Institutional Trust Company, N.A. 1.95M $13.32M June 30, 2015
Scopia Management 1.71M $26.67M June 30, 2012
GOLDMAN SACHS 1.59M $10.90M June 30, 2015
Tang Capital Management 1.55M $18.15M Sept. 30, 2012
BANK OF MONTREAL /CAN/ 1.52M $12.34M Sept. 30, 2014
Renaissance Technologies 1.39M $8.44M March 31, 2015
D. E. Shaw & Co 1.33M $11.14M Sept. 30, 2013
F^C Asset Management 1.30M $10.24M March 31, 2014
Deerfield Management Company 1.27M $9.92M March 31, 2014
DIMENSIONAL FUND ADVISORS 1.25M $7.60M March 31, 2015
Ashford Capital Management 1.25M $8.55M June 30, 2015
Royal Bank of Canada 1.17M $10.29M Dec. 31, 2013
Tom Rawlings 1.17M $7.07M March 31, 2015
Inves 1.16M $8.64M March 31, 2013
CITADEL ADVISORS 1.07M $6.49M March 31, 2015
Barclays 1.06M $6.40M Dec. 31, 2014
Wentworth, Hauser & Violich 1.05M $7.83M March 31, 2013